Generics News

The FDA has approved generic versions of the fluoroquinolone antibiotic Levaquin (levofloxacin).

Mylan has received final approval from the FDA to launch Budesonide Capsules, 3mg (enteric-coated), the generic version of Entocort EC (AstraZeneca) capsules.

Triamcinolone Acetonide Nasal Spray, a generic version of Nasacort AQ, indicated for the treatment of seasonal and perennial allergic rhinitis, has been made available by Teva.

Mylan has launched Bromfenac Ophthalmic Solution 0.09%, a generic version of Xibrom Ophthalmic Solution 0.09%.

The FDA has approved Teva’s ANDA to market a generic ­version of Combivir Tablets (lamivudine and zidovudine; GlaxoSmithKline).

Generic equivalents for Lybrel, Ortho-Cept, and Yasmin have been approved by the FDA.

Actavis has commenced with distribution of Zolpidem T­artrate Extended-Release Tablets in a 12.5mg strength.

Teva has launched the generic version of Femara (letrozole; Novartis), an antineo­plastic agent indicated for the treatment of breast cancer.

The FDA approved B. Braun Medical Inc.’s application for 1g and 2g Ceftazidime for Inj and Dextrose Inj in the DUPLEX Drug Delivery System, a ready-to-use two-compartment, IV con­tainer that stores pre-­measured drug and diluent doses.